首页> 外文期刊>American Journal of Physiology >Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension.
【24h】

Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension.

机译:特发性肺动脉高压中抗过度增殖凋亡的内皮细胞。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Idiopathic pulmonary arterial hypertension (IPAH) is characterized by plexiform vascular lesions, which are hypothesized to arise from deregulated growth of pulmonary artery endothelial cells (PAEC). Here, functional and molecular differences among PAEC derived from IPAH and control human lungs were evaluated. Compared with control cells, IPAH PAEC had greater cell numbers in response to growth factors in culture due to increased proliferation as determined by bromodeoxyuridine incorporation and Ki67 nuclear antigen expression and decreased apoptosis as determined by caspase-3 activation and TdT-mediated dUTP nick end labeling assay. IPAH cells had greater migration than control cells but less organized tube formation in in vitro angiogenesis assay. Persistent activation of signal transducer and activator of transcription 3 (STAT3), a regulator of cell survival and angiogenesis, and increased expression of its downstream prosurvival target, Mcl-1, were identified in IPAH PAEC. A Janus kinase (JAK) selective inhibitor reduced STAT3 activation and blocked proliferation of IPAH cells. Phosphorylated STAT3 was detected in endothelial cells of IPAH lesions in vivo, suggesting that STAT3 activation plays a role in the proliferative pulmonary vascular lesions in IPAH lungs.
机译:特发性肺动脉高压(IPAH)的特点是丛状血管病变,据推测是由于肺动脉内皮细胞(PAEC)生长失调引起的。在这里,评估了来自IPAH的PAEC和对照人肺之间的功能和分子差异。与对照细胞相比,IPAH PAEC对培养物中的生长因子有较大反应,这是由于溴脱氧尿嘧啶核苷掺入和Ki67核抗原表达确定了增殖的增加,而胱天蛋白酶3激活和TdT介导的dUTP缺口末端标记确定的凋亡减少了。分析。 IPAH细胞比对照细胞具有更大的迁移能力,但在体外血管生成测定中,管组织的形成较少。在IPAH PAEC中确定了信号转导子和转录激活子3(STAT3)的持久激活,这是细胞存活和血管生成的调节剂,其下游存活靶标Mcl-1的表达也有所增加。 Janus激酶(JAK)选择性抑制剂可降低STAT3激活并阻断IPAH细胞的增殖。在体内IPAH病变的内皮细胞中检测到磷酸化的STAT3,这表明STAT3激活在IPAH肺的增生性肺血管病变中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号